REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bio-Gen Sp. z o.o. (Poland)

Main Activities: Pesticide and Other Agricultural Chemical Manufacturing
Secondary Activities: Aquaculture | Dog and Cat Food Manufacturing | Other Animal Food Manufacturing | Nitrogenous Fertilizer Manufacturing | Livestock Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Miscellaneous Schools and Instruction
Full name: Bio-Gen Sp. z o.o. Profile Updated: August 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Bio-Gen is a biotechnology and genetic engineering company. The company offers a range of biological products, including imPROver+. Bio-Gen operates in the biotechnology and genetic engineering industry.

Headquarters
Ul. Pojezierska 97K
Lodz; Lodzkie; Postal Code: 91-341

Contact Details: Purchase the Bio-Gen Sp. z o.o. report to view the information.

Website: http://www.bio-gen.pl

Basic Information
Total Employees:
Purchase the Bio-Gen Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Bio-Gen Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Bio-Gen Sp. z o.o. report to view the information.
Incorporation Date:
May 25, 2004
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Company Performance
Financial values in the chart are available after Bio-Gen Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
23.91%▲
Total operating revenue
23.72%▲
Operating profit (EBIT)
-44.36%▼
EBITDA
-34.98%▼
Net Profit (Loss) for the Period
-50.58%▼
Total assets
26.27%▲
Total equity
23.96%▲
Operating Profit Margin (ROS)
-24.98%▼
Net Profit Margin
-23.1%▼
Return on Equity (ROE)
-26.78%▼
Debt to Equity Ratio
7.97%▲
Quick Ratio
-4%▼
Cash Ratio
-0.13%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo